Commit To Buy Quantum Computing At $3, Earn 19.3% Using Options

Quantum Computing Inc (QUBT) currently trades at $8.31 while the January 2028 $3 put would yield a 10% annualized return via a $0.58 premium but only results in ownership if the shares fall about 63.8%; effective cost basis upon assignment would be $2.42 before commissions. The note highlights the stock's high trailing-12-month volatility of 118%, and contextualizes options flow with an intraday S&P 500 put:call ratio of 0.73 versus a long-term median of 0.65, suggesting modestly elevated put demand relative to typical levels.

Analysis

Market structure: Elevated put activity and a 118% trailing vol for QUBT signals a short-dated skew in demand for downside protection in small-cap quantum names; winners are options sellers, exchanges (NDAQ) and brokers who collect fees, losers are leveraged holders and retail margin borrowers if a gap down occurs. The $3 Jan‑2028 put (58¢ premium → $2.42 effective buy price if assigned) offers ~10% annualized yield but requires a 63.8% fall to be exercised from $8.31, so liquidity providers and cash‑secured put sellers assume concentrated downside risk while collecting premium.

Risk assessment: Tail risks include balance‑sheet stress or failed product demos that could trigger >60% declines (assignment scenario), regulatory/contracting setbacks for quantum tech, and voluntary deleveraging by retail option sellers causing compressed liquidity; immediate risk (days–weeks) is volatility spikes and news-driven gaps, short‑term (months) is funding/earnings dilution, long‑term (years) is technology adoption failure. Hidden dependency: many put sellers may be retail/cash‑secured and lack capital to hold long positions on assignment, which could produce forced selling and feedback loops; catalyst set includes quarterly filings, funding updates, or a high‑profile technical milestone.

Trade implications: Direct trade — sell cash‑secured Jan‑2028 QUBT $3 puts sized to 1–2% of portfolio capital only if you are willing to take delivery at $2.42; set OCO to buy‑to‑close if QUBT < $5 (≈40% drop) or IV rises >+50% from entry. For market‑structure exposure, long NDAQ (2–4% position or 1–3 long‑dated calls, 6–12 month horizon) to capture structurally higher options revenue from elevated flows; avoid adding directional long QUBT equity without material fundamental derisking.

Contrarian angles: Consensus fears volatility; it underestimates that premium can be harvested profitably if disciplined — mispricing exists if sellers ignore assignment capacity. Historical parallels: micro‑cap tech episodes (2019–2021) where high IV compressed after funding rounds or buyouts; unintended consequence — mass cash‑secured put selling could amplify downside in a thin tape, so stress test capital needs under a 70% drawdown before executing.

Key Decisions for Investors

• Establish a cash‑secured short position: sell QUBT Jan‑2028 $3 puts sized so maximum assignment cost equals 1–2% of portfolio (i.e., capital reserved ≈$2.42 * (shares per contract) * number of contracts); collect ~58¢ premium, close if QUBT < $5 or IV > +50% vs entry, horizon 3–24 months.
• Buy NDAQ exposure to capture elevated option fee revenue: initiate a 2–4% long position in NDAQ stock or buy one 6–12 month 1.0–1.5x delta call (limit entry within next 30 days), target total return 15–25% if option volumes remain elevated.
• If worried about assignment or systemic vol-crunch, purchase protective puts on QUBT (12–24 month OTM, e.g., $5 strike) sized to offset equity risk, or alternatively execute a collar around any assigned position to cap downside below $2.42; monitor catalysts (earnings, funding news) in next 30–90 days for re‑pricing.
• Avoid outright long QUBT equity >0.5% of portfolio until either (a) cash runway ≥12 months or (b) share price sustains >$12 for 3 months; consider pair trade long NDAQ / short QUBT small‑cap tech basket if breadth shows persistent put buying and QUBT fundamentals don’t improve.